On May 20, the customs statistical data platform updated the import and export data. The export value of China’s COVID-19 reagents in May was 1.394 billion yuan, which is less than 10% of the value in January.

Chinese sequencing technology company Axbio said on Monday that it has secured $100 million in Series B financing.

On June 16, 2022, Shenzhen Living Water POCT held a strategic investment cooperation signing ceremony with 6 companies including BGI Co-Win, NEVC, Ruihai Invest, VDO Biotech, Zhouyu Fund, Great Wall fund.

Spatial proteomics firm Ionpath said on Wednesday that it has received a strategic investment of undisclosed size from Thermo Fisher Scientific.

On September 26, Hangzhou Matridx Biotechnology Co., Ltd. (hereinafter referred to as Matridx) announced that it had completed a strategic investment of hundreds of millions of yuan.

Mesa Laboratories said on Tuesday that it has acquired mass spectrometry-based genetic analysis firm Agena Bioscience for $300 million in cash.

Life science company RareCyte said on Thursday that it completed $24 million in financing from both new and existing investors.

QIAGEN to join the DAX on September 20, 2021, the effective date for changes in index composition. QIAGEN to remain in TecDAX comprised of the 30 largest German technology sector companies.

As of the end of August 2021, the first-half reports of IVD-related listed companies have basically been released. 64 IVD-related listed companies have achieved steady growth in the first half of 2021, and more than 70% of companies have shown positive growth in net profits.

On July 28, 2021, Thermo Fisher Scientific announcing that it would invest in the construction of another brand-new factory under Thermo Fisher China manufacturing center in Suzhou High Tech Zone. The total investment is $50 million, which is expected to be completed and put into use in 2022.